Yunyi Liu Selected Research

Toll-Like Receptor 2

1/2022	Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
1/2021	Paeoniflorin inhibits the macrophage-related rosacea-like inflammatory reaction through the suppressor of cytokine signaling 3-apoptosis signal-regulating kinase 1-p38 pathway.
1/2021	A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunyi Liu Research Topics

Disease

6	Neoplasms (Cancer) 06/2022 - 01/2013
5	Rosacea (Acne Rosacea) 09/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2022 - 05/2017
2	Inflammation (Inflammations) 01/2021 - 12/2019
1	Fibrosarcoma 06/2022
1	Myalgia 12/2019
1	Nasopharyngeal Carcinoma 01/2019
1	Latent Infection 01/2019
1	Epstein-Barr Virus Infections 01/2019
1	Breast Neoplasms (Breast Cancer) 05/2017
1	Neuroblastoma 07/2014
1	Liver Neoplasms (Liver Cancer) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2013
1	Experimental Melanoma 10/2011

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
3	Toll-Like Receptor 2IBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 12/2019
2	Carvedilol (Coreg)FDA LinkGeneric 01/2022 - 01/2021
2	SalicylatesIBA 01/2022 - 05/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
2	CytokinesIBA 01/2021 - 01/2021
2	CathelicidinsIBA 01/2021 - 01/2021
1	Nucleotide AptamersIBA 06/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2022
1	salinomycinIBA 01/2022
1	ZincIBA 01/2022
1	peoniflorinIBA 01/2021
1	MAP Kinase Kinase Kinase 5IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	Kallikreins (Kallikrein)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 12/2019
1	MagnesiumIBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019
1	SurvivinIBA 05/2017
1	CopperIBA 05/2017
1	cucurbitacin BIBA 07/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	germacroneIBA 01/2013
1	Monophenol Monooxygenase (Tyrosinase)IBA 10/2011
1	Melanins (Melanin)IBA 10/2011
1	sesaminIBA 10/2011

Therapy/Procedure

4	Therapeutics 06/2022 - 01/2021
1	Intradermal Injections 01/2021
1	Drug Therapy (Chemotherapy) 01/2021